TNSN06265A1 - Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics - Google Patents

Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics

Info

Publication number
TNSN06265A1
TNSN06265A1 TNP2006000265A TNSN06265A TNSN06265A1 TN SN06265 A1 TNSN06265 A1 TN SN06265A1 TN P2006000265 A TNP2006000265 A TN P2006000265A TN SN06265 A TNSN06265 A TN SN06265A TN SN06265 A1 TNSN06265 A1 TN SN06265A1
Authority
TN
Tunisia
Prior art keywords
human
aptamers
autoimmune disease
methods
cytokine family
Prior art date
Application number
TNP2006000265A
Other languages
French (fr)
Inventor
John L Diener
Alicia Ferguson
Nobuko Hamaguchi
Sara Chesworth Keene
H A Daniel Lagasse
Pooja Sawhney
Kristin Thompson
Original Assignee
Archemix Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/007666 external-priority patent/WO2005086835A2/en
Application filed by Archemix Corp filed Critical Archemix Corp
Publication of TNSN06265A1 publication Critical patent/TNSN06265A1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides materials and methods to treat immune disease in which cytokines are involved in pathogenesis. The materials and methods of the present invention are useful in the treatment of autoimmune diseases. The materials and methods of the present invention are directed to nucleic acid ligands capable of binding to human IL-23 and/or human IL-12 cytokines and thus modulate their biological activity and are useful as therapeutic agents in immune, auto-immune and cancer therapeutics.
TNP2006000265A 2004-09-07 2006-09-04 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics TNSN06265A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60804604P 2004-09-07 2004-09-07
PCT/US2005/007666 WO2005086835A2 (en) 2004-03-05 2005-03-07 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics

Publications (1)

Publication Number Publication Date
TNSN06265A1 true TNSN06265A1 (en) 2007-12-03

Family

ID=40308454

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2006000265A TNSN06265A1 (en) 2004-09-07 2006-09-04 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics

Country Status (2)

Country Link
CN (1) CN101356284A (en)
TN (1) TNSN06265A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113549624A (en) * 2021-06-29 2021-10-26 武汉大学 Thiophosphorus modified aptamer, thiophosphorus modified aptamer coupled T cell and preparation method and application thereof

Also Published As

Publication number Publication date
CN101356284A (en) 2009-01-28

Similar Documents

Publication Publication Date Title
WO2007035922A3 (en) Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
WO2005086835A3 (en) Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
EP2628751A3 (en) Binding members for interleukin-6 and use thereof
TNSN05300A1 (en) Treatment with anti-vegf antibodies
SI1615952T1 (en) Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
WO2004113571A3 (en) Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
UA108193C2 (en) APOPTOZINDUCE FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTO-IMMUNE DISEASES
DE69929232D1 (en) VIRUSELY PARTICLES FOR INDUCING AUTOANTIC BODIES
TW200630105A (en) Herbal composition PHY906 and its use in chemotherapy
CY1111714T1 (en) Binding Protein Growth Factor (HGF) Binding Proteins.
MXPA06000619A (en) Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy.
EA201000424A1 (en) ANTIBODIES TO IL-23
TW200732347A (en) VEGF analogs and methods of use
EA200700175A1 (en) COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY DISEASES
WO2005100998A3 (en) Membrane markers for use in cancer diagnosis and therapy
MX2007000023A (en) Interferon alpha receptor 1 antibodies and their uses.
EA200602137A1 (en) HYDROGEL PREPARATIONS OF INTERFERON
MX2021002605A (en) Anti-cxcl13 antibodies for treating autoimmune diseases and cancer.
MX2020008208A (en) Fibroblast binding agents and use thereof.
IL169367A0 (en) Defensin proteins
GB0418388D0 (en) Cell therapy
TW200724679A (en) Treatment of disease using an improved regulated expression system
TNSN06265A1 (en) Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
EA200700346A1 (en) BACTERIOPHAG- AND PROFAG-SPECIFIC PROTEINS IN CANCER GENETIC THERAPY
DE60130775D1 (en) STIMULATION OF THE NEUTROPHIL FUNCTION FOR THE TREATMENT OF INFLAMMATORY ENDURANCE DISEASES